» Articles » PMID: 32059628

Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United States

Abstract

Background: There are few studies evaluating regional disparities in the care of acute myocardial infarction-cardiogenic shock (AMI-CS).

Methods And Results: Using the National Inpatient Sample from 2000 to 2016, we identified adults with a primary diagnosis of AMI and concomitant CS admitted to the United States census regions of Northeast, Midwest, South, and West. Interhospital transfers were excluded. End points of interest included in-hospital mortality, use of coronary angiography, percutaneous coronary intervention, mechanical circulatory support, hospitalization costs, length of stay, and discharge disposition. Multivariable regression was used to adjust for potential confounding. Of the 402 825 AMI-CS admissions, 16.8%, 22.5%, 39.3%, and 21.4% were admitted to the Northeast, Midwest, South, and West, respectively. Higher rates of ST-elevation AMI-CS were noted in the Midwest and West. Admissions to the Northeast were on average characterized by a higher frequency of whites, Medicare beneficiaries, and lower rates of cardiac arrest. Admissions to the Northeast were less likely to receive coronary angiography, percutaneous coronary intervention, and mechanical circulatory support, despite the highest rates of extracorporeal membrane oxygenation use. Compared with the Northeast, in-hospital mortality was lower in the Midwest (adjusted odds ratio [aOR], 0.96 [95% CI, 0.93-0.98]; <0.001) and West (aOR, 0.96 [95% CI, 0.94-0.98]; =0.001) but higher in the South (aOR, 1.04 [95% CI, 1.01-1.06]; =0.002). The Midwest (aOR, 1.68 [95% CI, 1.62-1.74]; <0.001), South (aOR, 1.86 [95% CI, 1.80-1.92]; <0.001), and West (aOR, 1.93 [95% CI, 1.86-2.00]; <0.001) had higher discharges to home.

Conclusions: There remain significant regional disparities in the management and outcomes of AMI-CS.

Citing Articles

Clinical outcomes following shock team implementation for cardiogenic shock: a systematic review.

Abdelnabi M, Elsaeidy A, Aboutaleb A, Johanis A, Ghanem A, Rezq H Egypt Heart J. 2024; 76(1):163.

PMID: 39738825 PMC: 11685370. DOI: 10.1186/s43044-024-00594-z.


Hemodynamic-based Assessment and Management of Cardiogenic Shock.

Hernandez-Montfort J, Miranda D, Randhawa V, Sleiman J, Seijo de Armas Y, Lewis A US Cardiol. 2024; 16:e05.

PMID: 39600847 PMC: 11588170. DOI: 10.15420/usc.2021.12.


The Price We Pay for Progression in Shock Care: Economic Burden, Accessibility, and Adoption of Shock-Teams and Mechanical Circulatory Support Devices.

Vallabhajosyula S, Sinha S, Kochar A, Pahuja M, Amico Jr F, Kapur N Curr Cardiol Rep. 2024; 26(10):1123-1134.

PMID: 39325244 DOI: 10.1007/s11886-024-02108-4.


Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.

Azhar Ud Din M, Wan A, Chu Y, Zhou J, Yan Y, Xu Z Front Med (Lausanne). 2024; 11:1406547.

PMID: 39139783 PMC: 11319305. DOI: 10.3389/fmed.2024.1406547.


Impact of Socioeconomic Status on Mechanical Circulatory Device Utilization and Outcomes in Cardiogenic Shock.

Adelsheimer A, Wang J, Lu D, Elbaum L, Krishnan U, Cheung J J Soc Cardiovasc Angiogr Interv. 2024; 1(2):100027.

PMID: 39132559 PMC: 11307802. DOI: 10.1016/j.jscai.2022.100027.


References
1.
Khera R, Krumholz H . With Great Power Comes Great Responsibility: Big Data Research From the National Inpatient Sample. Circ Cardiovasc Qual Outcomes. 2017; 10(7). PMC: 5728376. DOI: 10.1161/CIRCOUTCOMES.117.003846. View

2.
Vallabhajosyula S, Patlolla S, Sandhyavenu H, Vallabhajosyula S, Barsness G, Dunlay S . Periprocedural Cardiopulmonary Bypass or Venoarterial Extracorporeal Membrane Oxygenation During Transcatheter Aortic Valve Replacement: A Systematic Review. J Am Heart Assoc. 2018; 7(14). PMC: 6064861. DOI: 10.1161/JAHA.118.009608. View

3.
Vallabhajosyula S, Arora S, Sakhuja A, Lahewala S, Kumar V, Shantha G . Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock. Am J Cardiol. 2018; 123(3):489-497. DOI: 10.1016/j.amjcard.2018.10.029. View

4.
Pilote L, Califf R, Sapp S, Miller D, Mark D, Weaver W . Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med. 1995; 333(9):565-72. DOI: 10.1056/NEJM199508313330907. View

5.
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J . Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43(11):1130-9. DOI: 10.1097/01.mlr.0000182534.19832.83. View